David Hoenig, MD
Urology · Lake Success, NYNPI 1457467086
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $600 of the $874 with a category attached, or 68.7%. Urogen Pharma, Inc. accounts for 71.4% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $600 and has fallen 77.4% since, to $136 in 2025. That places this record below the midpoint for urology clinicians in NY, where the typical reported total is $2,467.
Across 5 payments — averaging $174.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Urogen Pharma, Inc.$624
- Calyxo, Inc.$136
- Novo Nordisk Health Care AG$114
Across 1 payment — averaging $13,790 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Urogen Pharma, Inc.$14K
What the payments were for
- Consulting fees$60069%
- Food & beverage$25029%
- Education$243%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Urogen Pharma, Inc. | 3 | $624 |
| Calyxo, Inc. | 1 | $136 |
| Novo Nordisk Health Care AG | 1 | $114 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JELMYTO$600
- CVAC Aspiration System$136
How this compares
$874 in reported general payments places this provider in the 30th percentile of 952 urology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Citrate ErPotassium Citrate | 307 | $43,793 |
| MyrbetriqMirabegron | 30 | $34,209 |
| Methenamine Hippurate | 88 | $10,814 |
| Tamsulosin Hcl | 324 | $5,181 |
| Estradiol | 47 | $4,139 |
| Finasteride | 239 | $3,083 |
| Oxybutynin Chloride ErOxybutynin Chloride | 43 | $1,358 |
| Allopurinol | 56 | $605 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 27 | $485 |
| Chlorthalidone | 21 | $443 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 26 | $432 |
| Cephalexin | 16 | $354 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $269 |
| Hydrochlorothiazide | 75 | $251 |
| CefuroximeCefuroxime Axetil | 19 | $166 |
Paid to pharmacies, not to this prescriber.
Other urology in Lake Success
- Peter WalterJamestown$1.9M
- Christopher PieczonkaSyracuse$797K
- Bilal ChughtaiNew York$658K
- Katie MurrayNew York$575K
- Neil BanderNew York$544K
- Robert ValenzuelaNew York$494K
- Jeffrey SpencerCheektowaga$430K
- Kyrollis AttallaNew York$381K
- Benjamin BruckerNew York$364K
- Evan GoldfischerPoughkeepsie$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.